- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Pathology
Volume 2012 (2012), Article ID 568062, 3 pages
Malignant Transformation in a Mature Teratoma with Metastatic Deposits in the Omentum: A Case Report
Department of Pathology, JIPMER, Puducherry 605006, India
Received 18 July 2012; Accepted 9 September 2012
Academic Editors: T. Ozawa and M. M. Picken
Copyright © 2012 Shramana Mandal and Bhawana A. Badhe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Malignant transformation of a mature cystic teratoma (MCT) is a very rare complication with an incidence of 0.17–2%;. The most common form of malignant transformation of the MCT is squamous cell carcinoma. Other tumors arising in MCT include basal cell carcinoma, sebaceous tumor, malignant melanoma, adenocarcinoma, sarcoma, and neuroectodermal tumor. However malignant transformation with metastatic deposits in the omentum is extremely rare. The present case highlights the rarity of the occurrence of an omental deposits in a case of mature cystic teratoma with malignant transformation.
Malignant transformation in a mature cystic teratoma (MCT) is extremely rare . Its incidence is 0.17–2% of all cases. MCT with deposits in the omentum is even rarer. The exact incidence is not known. The prognosis of malignant transformation of the MCT is very poor . Extensive literature search has revealed only 3 such cases. We report the fourth case of MCT with omental deposits of squamous cell carcinoma in a 56-year-old female.
2. Case Report
A 56-year-old female presented with history of abdominal distension and pain for 5 months. On per vaginal examination, a mass was felt arising from the pelvis, which was cystic, nontender, and mobile. The border of the mass was not well defined. Grossly a multiloculated ovarian mass was received measuring cm in size with an area of capsular breech. Cut surface was multiloculated, cystic, filled with grumous material, hair, and tooth. A single solid island measuring cm was also identified, the cut surface of which was grey white and firm. Microscopical sections showed typical features of a mature cystic teratoma. The cyst wall was composed of ectodermal elements (Figure 1). Section from the solid areas showed well-differentiated squamous cell carcinoma arising from the surface epithelium (Figure 2). Omentum showed deposits of well-differentiated squamous cell carcinoma. A final diagnosis of malignant transformation of well-differentiated squamous cell carcinoma in a mature cystic teratoma with omental deposits was made.
The mature cystic teratoma (MCT) is the most common germ cell tumor of ovary, comprising of more than 10–20% of all ovarian neoplasms . It is composed of a well-differentiated derivation of all the three germ cell layers, that is, endoderm, mesoderm, and ectoderm. Mature cystic teratomas can occur at any age; however, they are very common in women of childbearing age and occur bilaterally in 10–17% of patients . The complications associated with cystic teratoma cases include torsion (16%), malignant degeneration (2%), rupture into adjacent organs (1-2%), and infection (1%) .
Malignant change is rarely recognized preoperatively. Most patients with such tumours have symptoms of abdominal pain and mass, which do not differ from those of uncomplicated mature cystic teratomas such as abdominal pain and mass. These tumours range in sizes from 30 mm to 400 mm [1, 4]. The risk of malignancy is related to age and is substantially greater in postmenopausal women, the highest incidence being in the fifth and sixth decades of life .
Malignant transformation of an MCT is an uncommon complication occurring in approximately 0.17–2% of all mature cystic teratomas [4, 6]. Although any of the constituent tissues of teratoma has the potential to undergo malignant transformation, squamous cell carcinoma is the most commonly associated cancer. However malignant transformation with metastasis to the omentum is extremely rare.
Rarely, other tumors (0.2–1.4%) can arise in an MCT like adenocarcinoma, basal cell carcinoma, adenosquamous carcinoma, thyroid carcinoma, sebaceous carcinoma, malignant melanoma, sarcoma, carcinoid tumor, and neuroectodermal tumour .
The low incidence of secondary malignant transformation of mature cystic teratoma explains why a few reports have been published. It has been thought that squamous cell carcinoma in mature cystic teratoma arises from metaplastic squamous epithelium . Furthermore, high-risk human papillomavirus infection has also been thought to be associated with ovarian squamous-cell carcinoma . Mostly mature cystic teratomas are detected 15–20 years before they undergo secondary malignant transformation. Cytogenetic abnormalities might precede histological changes, and prolonged exposure to various carcinogens in the pelvic cavity might cause the malignant changes in mature tissue. Thus, squamous-cell carcinoma in mature cystic teratoma is more common in postmenopausal patients. Pelvic ultrasonography can help in early detection of these tumours in women of childbearing age .
Grossly these tumours show presence of nodular, papillary, or cauliflower-like growths protruding into the cyst cavities or nodules or plaques within the cyst walls along with areas of capsular invasion.
Serum tumour markers like squamous cell carcinoma antigen, CA125, CA19-9, and CEA are useful in distinguishing mature cystic teratoma from malignant transformation. Tissue polypeptide antigen and macrophage colony stimulating factor may also help to predict malignant transformation in this tumour .
Because all preoperative diagnostic procedures can sometimes be unreliable in excluding malignant disease, all mature cystic teratomas in women more than 30 years that show unusual adherence, solid or firm, friable, myxomatous, or variegated areas should arouse suspicion. Hence, surgical approach should be chosen carefully based on the results of clinical and imaging investigations as well as tumour marker profiles .
Removal of the entire tumour, in accordance with oncosurgical treatment principles, is essential, following which complete cytoreduction can further improve the outcome in these patients. Alkylating drugs can be given for chemotherapy regimens, whereas, radiotherapy can lead to greater morbidity [4, 10].
To conclude, early detection and complete surgical resection are important for long-term survival. Adequate sampling is essential in these ovarian tumors to establish their teratomatous origin and avoid an erroneous diagnosis.
- J. H. Park, S. O. Whang, E. S. Song, S. J. Choi, and W. Y. Lee, “An ovarian mucinous cystadenocarcinoma arising from mature cystic teratoma with para-aortic lymph node metastasis: a case report,” Journal of Gynecologic Oncology, vol. 19, no. 4, pp. 275–278, 2008.
- T. M. Ulbright, “Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues,” Modern Pathology, vol. 18, no. 2, pp. S61–S79, 2005.
- P. C. Wang, T. L. Yang, and H. B. Pan, “CT images of a malignant-transformed ovarian mature cystic teratoma with rupture: a case report,” Korean Journal of Radiology, vol. 9, no. 5, pp. 458–461, 2008.
- A. Hackethal, D. Brueggmann, M. K. Bohlmann, F. E. Franke, H. R. Tinneberg, and K. Münstedt, “Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data,” The Lancet Oncology, vol. 9, no. 12, pp. 1173–1180, 2008.
- A. Gordon, N. Rosenshein, T. Parmley, and B. Bhagavan, “Benign cystic teratomas in postmenopausal women,” American Journal of Obstetrics and Gynecology, vol. 138, no. 8, pp. 1120–1123, 1980.
- S. Mandal, K. Dhingra, P. Gupta, and N. Khurana, “Rare growth of a psammomatous meningioma in a mature ovarian Teratoma: a case report,” Pathology Research and Practice, vol. 206, no. 5, pp. 322–324, 2010.
- A. Iwasa, Y. Oda, E. Kaneki et al., “Squamous cell carcinoma arising in mature cystic teratoma of the ovary: an immunohistochemical analysis of its tumorigenesis,” Histopathology, vol. 51, no. 1, pp. 98–104, 2007.
- J. Verguts, F. Amant, P. Moerman, and I. Vergote, “HPV induced ovarian squamous cell carcinoma: case report and review of the literature,” Archives of Gynecology and Obstetrics, vol. 276, no. 3, pp. 285–289, 2007.
- S. Y. Rim, S. M. Kim, and H. S. Choi, “Malignant transformation of ovarian mature cystic teratoma,” International Journal of Gynecological Cancer, vol. 16, no. 1, pp. 140–144, 2006.
- K. Yamaguchi, M. Mandai, K. Fukuhara et al., “Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period,” Oncology Reports, vol. 19, no. 3, pp. 705–711, 2008.